The use of monoreassortants and reverse genetics to map reovirus lysis of a ras-transformed cell line

Journal of Virological Methods

Volumn 139, Issue 2, 2007, Pages 132-142

  Roner, Michael R ^a   Mutsoli, Christine ^a  

^a UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

Monoreassortants; Reovirus; Reverse genetics; S4; Sigma 3

Indexed keywords

ONCOLYTIC VIRUS;

ANIMAL CELL; ARTICLE; CELL LINE; CELL MUTANT; CELL STRAIN; CONTROLLED STUDY; CYTOLYSIS; EMBRYO; GENE MAPPING; GENETIC LINKAGE; GENETIC REASSORTMENT; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROGENY; REOVIRUS; REVERTANT; SEROTYPE; T LYMPHOCYTE; VIRAL GENETICS; VIRUS CELL TRANSFORMATION; VIRUS GENE;

CELL LINE, TRANSFORMED; GENETIC TECHNIQUES; RAS PROTEINS; REASSORTANT VIRUSES; REOVIRIDAE; TUMOR CELLS, CULTURED;

ORTHOREOVIRUS;

EID: 33846065095     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.09.016     Document Type: Article

References (34)

1. Antczak J.B., and Joklik W.K. Reovirus genome segment assortment into progeny genomes studied by the use of monoclonal antibodies directed against reovirus proteins. Virology 187 (1992) 760-776
2. Bell T.M., and Ross M.G. Persistent latent infection of human embryonic cells with reovirus type 3. Nature 212 (1966) 412-414
3. Boguski M.S., and McCormick F. Proteins regulating Ras and its relatives. Nature 366 (1993) 643-654
4. Danis C., Garzon S., and Lemay G. Further characterization of the ts453 mutant of mammalian orthoreovirus serotype 3 and nucleotide sequence of the mutated S4 gene. Virology 190 (1992) 494-498
5. Denzler K.L., and Jacobs B.L. Site-directed mutagenic analysis of reovirus sigma 3 protein binding to dsRNA. Virology 204 (1994) 190-199
6. Duncan M.R., Stanish S.M., and Cox D.C. Differential sensitivity of normal and transformed human cells to reovirus infection. J. Virol. 28 (1978) 444-449
7. Kedl R., Schmechel S., and Schiff L. Comparative sequence analysis of the reovirus S4 genes from 13 serotype 1 and serotype 3 field isolates. J. Virol. 69 (1995) 552-559
8. Kolli S., Zito C.I., Mossink M.H., Wiemer E.A., and Bennett A.M. The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J. Biol. Chem. 279 (2004) 29374-29385
9. Lee P.W., Hayes E.C., and Joklik W.K. Characterization of anti-reovirus immunoglobulins secreted by cloned hybridoma cell lines. Virology 108 (1981) 134-146
10. Leone G., DeGregori J., Sears R., Jakoi L., and Nevins J.R. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387 (1997) 422-426
11. Liu R., Li B., and Qiu M. Elevated superoxide production by active H-ras enhances human lung WI-38VA-13 cell proliferation, migration and resistance to TNF-alpha. Oncogene 20 (2001) 1486-1496
12. Loh P.C., and Soergel M. Growth characteristics of reovirus type 2: actinomycin D and the synthesis of viral RNA. Proc. Natl. Acad. Sci. U.S.A. 54 (1965) 857-863
13. Mabrouk T., and Lemay G. Mutations in a CCHC zinc-binding motif of the reovirus sigma 3 protein decrease its intracellular stability. J. Virol. 68 (1994) 5287-5290
14. Miller J.E., and Samuel C.E. Proteolytic cleavage of the reovirus sigma 3 protein results in enhanced double-stranded RNA-binding activity: identification of a repeated basic amino acid motif within the C-terminal binding region. J. Virol. 66 (1992) 5347-5356
15. Moody M.D., and Joklik W.K. The function of reovirus proteins during the reovirus multiplication cycle: analysis using monoreassortants. Virology 173 (1989) 437-446
16. Norman K.L., Hirasawa K., Yang A.D., Shields M.A., and Lee P.W. Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 11099-11104
17. Rodgers S.E., Barton E.S., Oberhaus S.M., Pike B., Gibson C.A., Tyler K.L., and Dermody T.S. Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J. Virol. 71 (1997) 2540-2546
18. Roner M.R., and Cox D.C. Cellular integrity is required for inhibition of initiation of cellular DNA synthesis by reovirus type 3. J. Virol. 53 (1985) 350-359
19. Roner M.R., Lin P.N., Nepluev I., Kong L.J., and Joklik W.K. Identification of signals required for the insertion of heterologous genome segments into the reovirus genome. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 12362-12366
20. Roner M.R., Nepliouev I., Sherry B., and Joklik W.K. Construction and characterization of a reovirus double temperature-sensitive mutant. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 6826-6830
21. Roner M.R., and Roehr J. The 3′ sequences required for incorporation of an engineered ssRNA into the Reovirus genome. Virol. J. 3 (2006) 1
22. Roner M.R., Sutphin L.A., and Joklik W.K. Reovirus RNA is infectious. Virology 179 (1990) 845-852
23. Rudd P., and Lemay G. Correlation between interferon sensitivity of reovirus isolates and ability to discriminate between normal and Ras-transformed cells. J. Gen. Virol. 86 (2005) 1489-1497
24. Schiff L.A., Nibert M.L., Co M.S., Brown E.G., and Fields B.N. Distinct binding sites for zinc and double-stranded RNA in the reovirus outer capsid protein sigma 3. Mol. Cell. Biol. 8 (1988) 273-283
25. Schmechel S., Chute M., Skinner P., Anderson R., and Schiff L. Preferential translation of reovirus mRNA by a sigma3-dependent mechanism. Virology 232 (1997) 62-73
26. Shmulevitz M., Marcato P., and Lee P.W. Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer. Oncogene 24 (2005) 7720-7728
27. Smith J.A., Schmechel S.C., Williams B.R., Silverman R.H., and Schiff L.A. Involvement of the interferon-regulated antiviral proteins PKR and RNase L in reovirus-induced shutoff of cellular translation. J. Virol. 79 (2005) 2240-2250
28. Spandidos D.A., and Wilkie N.M. Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature 310 (1984) 469-475
29. St Johnston D., Brown N.H., Gall J.G., and Jantsch M. A conserved double-stranded RNA-binding domain. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 10979-10983
30. Strong J.E., Coffey M.C., Tang D., Sabinin P., and Lee P.W. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J. 17 (1998) 3351-3362
31. Strong J.E., and Lee P.W. The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection. J. Virol. 70 (1996) 612-616
32. Telang N.T., Narayanan R., Bradlow H.L., and Osborne M.P. Coordinated expression of intermediate biomarkers for tumorigenic transformation in RAS-transfected mouse mammary epithelial cells. Breast Cancer Res. Treat. 18 (1991) 155-163
33. Telang N.T., Osborne M.P., Sweterlitsch L.A., and Narayanan R. Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression. Cell Regul. 1 (1990) 863-872
34. Tyler K.L., Squier M.K., Brown A.L., Pike B., Willis D., Oberhaus S.M., Dermody T.S., and Cohen J.J. Linkage between reovirus-induced apoptosis and inhibition of cellular DNA synthesis: role of the S1 and M2 genes. J. Virol. 70 (1996) 7984-7991